EP400 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.288800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.351200E-01
Normal-vs-Stage2
3.115400E-01
Normal-vs-Stage3
7.668300E-02
Normal-vs-Stage4
2.834800E-01
Stage1-vs-Stage2
8.703800E-02
Stage1-vs-Stage3
3.267900E-02
Stage1-vs-Stage4
5.470200E-01
Stage2-vs-Stage3
7.038100E-02
Stage2-vs-Stage4
5.836800E-01
Stage3-vs-Stage4
1.232410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.414400E-01
Normal-vs-AfricanAmerican
2.656200E-01
Normal-vs-Asian
3.413900E-02
Caucasian-vs-AfricanAmerican
3.445000E-01
Caucasian-vs-Asian
1.205380E-01
AfricanAmerican-vs-Asian
8.390600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.089800E-02
Normal-vs-Female
3.222800E-01
Male-vs-Female
6.800800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.335000E-01
Normal-vs-Age(41-60Yrs)
3.716600E-01
Normal-vs-Age(61-80Yrs)
1.338480E-02
Normal-vs-Age(81-100Yrs)
5.946000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.910820E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.666630E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.271000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.940500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.056200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.870800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.866200E-01
Normal-vs-Daily Drinker
3.312600E-01
Normal-vs-Weekly Drinker
4.972100E-02
Normal-vs-Occasional Drinker
3.827200E-01
Normal-vs-Social Drinker
8.499500E-02
Non Drinker-vs-Daily Drinker
4.674800E-01
Non Drinker-vs-Weekly Drinker
6.571400E-01
Non Drinker-vs-Occasional Drinker
1.446820E-01
Non Drinker-vs-Social Drinker
2.111600E-01
Daily Drinker-vs-Weekly Drinker
8.618800E-01
Daily Drinker-vs-Occasional Drinker
4.516400E-01
Daily Drinker-vs-Social Drinker
5.315400E-01
Weekly Drinker-vs-Occasional Drinker
3.908200E-01
Weekly Drinker-vs-Social Drinker
4.826600E-01
Occasional Drinker-vs-Social Drinker
9.905800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.445000E-01
Normal-vs-Grade 2
5.864400E-01
Normal-vs-Grade 3
5.595000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.080200E-01
Grade 1-vs-Grade 3
3.582200E-01
Grade 1-vs-Grade 4
2.445000E-01
Grade 2-vs-Grade 3
4.573400E-01
Grade 2-vs-Grade 4
5.864400E-01
Grade 3-vs-Grade 4
5.595000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.045800E-01
Normal-vs-NonDiabetic
1.995550E-02
Diabetic-vs-NonDiabetic
4.965800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.900600E-01
Normal-vs-NoPancreatitis
3.236600E-01
Pancreatitis-vs-NoPancreatitis
5.599800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.923700E-02
Normal-vs-N1
3.094000E-01
N0-vs-N1
2.904200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.927800E-01
Normal-vs-TP53-NonMutant
1.155360E-01
TP53-Mutant-vs-TP53-NonMutant
8.997500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
